Arrowhead Pharmaceuticals, Inc.
ARWRNasdaqCIK 879407HealthcareFiscal year ends Sep 30
Reports and events: 292 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000879407-26-000058 |
| 2026-08-0416:02 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000879407-26-000057 |
| 2026-06-1616:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000879407-26-000050 |
| 2026-05-0716:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000879407-26-000047 |
| 2026-05-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000879407-26-000045 |
| 2026-03-2016:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000879407-26-000037 |
| 2026-02-0516:06 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0000879407-26-000034 |
| 2026-02-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000879407-26-000033 |
| 2026-01-2717:32 ET | DEF 14A | Proxy statementPeriod 2026-01-26 | 0000879407-26-000019 |
| 2026-01-1217:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-010582 |
| 2026-01-0919:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-007971 |
| 2026-01-0616:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000879407-26-000004 |
| 2025-11-2516:13 ET | 10-K | Annual reportPeriod 2025-09-30 | 0000879407-25-000029 |
| 2025-11-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000879407-25-000027 |
| 2025-11-1814:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000879407-25-000019 |
| 2025-10-1016:02 ET | 10-K/A | Annual report, amendedPeriod 2024-09-30 | 0000879407-25-000013 |
| 2025-09-1216:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000879407-25-000010 |
| 2025-09-1107:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000879407-25-000007 |
| 2025-09-0216:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000879407-25-000004 |
| 2025-08-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038867 |
| 2025-08-0716:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038858 |
| 2025-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-024675 |
| 2025-05-1216:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-024666 |
| 2025-04-1515:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-017844 |
| 2025-03-1919:49 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-013619 |
| 2025-02-1016:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-004637 |
| 2025-02-1016:02 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001628280-25-004634 |
| 2025-02-0718:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-004313 |
| 2025-01-2917:33 ET | DEF 14A | Proxy statementPeriod 2025-01-28 | 0001628280-25-002848 |
| 2024-12-1817:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-051729 |
| 2024-11-2616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-049281 |
| 2024-11-2616:18 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001628280-24-049277 |
| 2024-08-0816:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-036113 |
| 2024-08-0816:03 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036104 |
| 2024-05-0916:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-022233 |
| 2024-05-0916:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022215 |
| 2024-03-1916:38 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-011930 |
| 2024-03-1819:21 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001628280-24-011557 |
| 2024-02-2217:42 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-24-005998 |
| 2024-02-0616:13 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001628280-24-003492 |
| 2024-02-0616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-003488 |
| 2024-01-2617:25 ET | DEF 14A | Proxy statementPeriod 2024-01-26 | 0001628280-24-002375 |
| 2024-01-2218:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-001805 |
| 2024-01-0417:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-24-000480 |
| 2023-12-0517:16 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-23-040776 |
| 2023-11-2916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-040222 |
| 2023-11-2916:09 ET | 10-K | Annual reportPeriod 2023-09-30 | 0001628280-23-040219 |
| 2023-08-0716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027779 |
| 2023-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027771 |
| 2023-05-0216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-014859 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.